The Prix Galien Russia Committee will judge which among the candidates, independent of any category, is the “Best Pharmaceutical Agent” (i.e. small molecule), is the “Best Biotechnology Product”, is the “Best Orphan Drug” and which is the “Best Medical Technology” approved by the Russian Ministry of health, or the FDA or the EMA in the past three years. The prizes are awarded for products and agents that improve the human condition and judged by the Jury to have most contributed to patient care in terms of efficacy, safety, benefits and innovation.

In addition, the Prix Galien Russia Comittee will present the “Galien Russia – Research Russia” awards, to the company, institute, or group of scientist that have developed a product or conducted a research program for at least three years in Russia, judged by the Jury to have made the most significant overall contribution to patient care in Russia in terms of efficacy, safety, benefits and innovation or to the advancement of science in Russia.



  • Galien Russia — Research
  • Pharmaceutical Agent
  • Biotechnology Product
  • Orphan Drugs

Medical Devices:

  • Med Tech


  • To be eligible, products must have received marketing approval in the Russian Federation and/or the FDA and/or the EMA from 1st of January 2013 to December 31, 2015.
  • The Research in Russia Award is open to any person or team who has been involved for at least the last three years in biopharmaceutical research leading or making a substantial contribution to the diagnosis, prevention or treatment of disease. Candidates from academia, health care institutions, research centers and industry are eligible.


Submissions must be received before May 30th 2016. Enter contact information to receive submission and pricing information.

Apply Now

First name: *
Last name: *
Company: *
Title: *
Phone: *
Email: *
Enter the Code: * captcha